0001437749-19-020230.txt : 20191017 0001437749-19-020230.hdr.sgml : 20191017 20191017211608 ACCESSION NUMBER: 0001437749-19-020230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191015 FILED AS OF DATE: 20191017 DATE AS OF CHANGE: 20191017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mathers James CENTRAL INDEX KEY: 0001676166 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 191156516 MAIL ADDRESS: STREET 1: C/O BIOLIFE SOLUTIONS STREET 2: 3303 MONTE VILLA PARKWAY, SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2019-10-15 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001676166 Mathers James C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL WA 98021 1 Vice President, Global Sales Common Stock 2019-10-15 4 M 0 2500 1.64 A 19884 D Common Stock 2019-10-15 4 S 0 2500 16.06 D 17384 D Common Stock 2019-10-16 4 M 0 2307 1.64 A 19691 D Common Stock 2019-10-16 4 S 0 2307 16.03 D 17384 D Common Stock 2019-10-17 4 M 0 2693 1.64 A 20077 D Common Stock 2019-10-17 4 S 0 2693 16.42 D 20077 D Employee Stock Option 1.64 2019-10-15 4 M 0 2500 0 D 2019-03-01 2021-12-20 Common Stock 2500 60113 D Employee Stock Option 1.64 2019-10-16 4 M 0 2307 0 D 2019-03-01 2021-12-20 Common Stock 2307 57806 D Employee Stock Option 1.64 2019-10-17 4 M 0 2693 0 D 2019-03-01 2021-12-20 Common Stock 2693 55113 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.06 to $16.07, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.02 to $16.145, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.38 to $16.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range /s/ James Mathers 2019-10-17